ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,419.78
-0.22%
Dow Jones
39,865.99
-0.01%
Gold vs US Dollar
2,405.075
1.13%
Brent Oil
83.45
0.29%
Bitcoin
67,254.60
3.09%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Kalvista Pharmaceuticals (MM) (CBYL)

  7. Kalvista Pharmaceuticals (MM) (CBYL) News

CARBYLAN THERAPEUTICS, INC. (CBYL)

Kalvista Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CBYL
DateTimeSourceHeadlineSymbolCompany
30/11/201621:25Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/11/201621:16Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/11/201622:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/11/201618:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/11/201621:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/11/201621:15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
21/11/201621:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
08/11/201621:18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
04/11/201620:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
28/10/201611:11Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
26/10/201621:17Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/09/201621:59Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
30/09/201621:10Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/09/201612:53PR Newswire (US)Carbylan Shareholder (CBYL) Alert: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues its Investigation of Carbylan...NASDAQ:CBYLKalvista Pharmaceuticals (MM)
12/09/201618:38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/08/201611:02Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (preliminary) (prem14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
12/08/201621:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
29/07/201621:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
28/06/201621:13Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
27/06/201622:21Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201621:21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201621:19Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
24/06/201621:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
23/06/201622:30Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201621:48Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201621:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
22/06/201621:00GlobeNewswire Inc.Carbylan Therapeutics and KalVista Pharmaceuticals Conference Call to Discuss Proposed TransactionNASDAQ:CBYLKalvista Pharmaceuticals (MM)
17/06/201611:04Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
15/06/201612:53Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
15/06/201612:51Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CBYLKalvista Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:CBYL

Your Recent History

LSE
ENET
Ethernity Networks
LSE
TERN
Tern
LSE
VAST
Vast Resources
LSE
EZJ
Easyjet
LSE
MIN
Minoan
LSE
CUSN
Cornish Metals
LSE
GKP
Gulf Keystone Petroleum
LSE
JLP
Jubilee Metals
LSE
THG
Thg
LSE
AAZ
Anglo Asian Mining
LSE
CHRY
Chrysalis Investments
LSE
RR.
Rolls-royce
LSE
ORCH
Orchard Funding
LSE
PXC
Phoenix Copper
LSE
BIRD
Blackbird
LSE
GDR
Genedrive
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved